NCT03082963View on ClinicalTrials.gov

Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

June 18, 2022

Study Completion Date

June 18, 2022

Conditions
Atrial Fibrillation
Interventions
DEVICE

Electrogram Morphology Mapping (EMR)

Fifteen second AF recordings will be made using a multipolar electrode catheter to map the entire right atrium \& then the left atrium.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Jeffrey Goldberger

OTHER

NCT03082963 - Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter